Telepharmacy for the management of cardiovascular patients in the community.

Simple item page
dc.contributor.authorOmboni, Stefano
dc.contributor.authorTenti, Mauro
dc.date.accessioned2020-06-08T14:16:47Z
dc.date.available2020-06-08T14:16:47Z
dc.date.issued0000-00-00
dc.description.abstractTelepharmacy is devised to provide pharmacy operations and patient care at a distance and to expand access to healthcare enhance patients safety and improve patient outcomes A variety of technologies models of care and interventions are used to develop and provide telepharmacy services serving diversified populations with different pathological conditions including cardiovascular diseases Unfortunately very few randomized controlled studies have evaluated the clinical efficacy of the implementation of telepharmacy services in the management of various cardiovascular conditions with the strongest evidence being limited to telemonitoring studies in the areas of hypertension and diabetes Although the clinical efficacy of telepharmacy and its cost effectiveness are far from being fully proved the inclusion of telepharmacy services in healthcare models may offer the unique opportunity to increase access to screening and improve care of cardiovascular conditions
dc.identifier.urihttp://dx.doi.org/10.1016/j.tcm.2018.07.002
dc.identifier.urihttps://lib.digitalsquare.io/handle/123456789/63306
dc.relation.uriTrends in cardiovascular medicine
dc.titleTelepharmacy for the management of cardiovascular patients in the community.en
dcterms.abstractTelepharmacy is devised to provide pharmacy operations and patient care at a distance and to expand access to healthcare enhance patients safety and improve patient outcomes A variety of technologies models of care and interventions are used to develop and provide telepharmacy services serving diversified populations with different pathological conditions including cardiovascular diseases Unfortunately very few randomized controlled studies have evaluated the clinical efficacy of the implementation of telepharmacy services in the management of various cardiovascular conditions with the strongest evidence being limited to telemonitoring studies in the areas of hypertension and diabetes Although the clinical efficacy of telepharmacy and its cost effectiveness are far from being fully proved the inclusion of telepharmacy services in healthcare models may offer the unique opportunity to increase access to screening and improve care of cardiovascular conditions
dcterms.contributorOmboni, Stefano
dcterms.contributorTenti, Mauro
dcterms.identifierhttp://dx.doi.org/10.1016/j.tcm.2018.07.002
dcterms.relationTrends in cardiovascular medicine
dcterms.titleTelepharmacy for the management of cardiovascular patients in the community.en
Files
Collections
mhealth Evidence